Clinical Trial: 68Ga-MY6349 PET/CT in Solid Tumors

U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07046702) titled '68Ga-MY6349 PET/CT in Solid Tumors' on June 23.

Brief Summary: The objective of the study is to construct a noninvasive approach 68Ga-MY6349 PET/CT to detect the Trop-2 expression of tumor lesions in patients with solid tumors and to identify patients benefiting from Trop-2 PET/CT.

Study Start Date: Dec. 10, 2024

Study Type: OBSERVATIONAL

Condition: Solid Tumor Trop2 PET/CT

Intervention: DIAGNOSTIC_TEST: 68Ga-MY6349

Each subject receives a single intravenous injection of 68Ga-MY6349 and undergoes PET/CT imaging within the specified time.

Recruitment Status: RECRUITING

Sponsor: The First Affiliated Hospital of Xiamen Universi...